Interactions of serum with lung surfactant extract in the bronchiolar and alveolar airway models

Respiratory Physiology and Neurobiology

Volumn 157, Issue 2-3, 2007, Pages 411-424

  Nag, Kaushik ^a   Hillier, Ashley ^a   Parsons, Kyle ^a   Garcia, Mauricia Fritzen ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Acute respiratory distress syndrome; Airway patency; Alveolar interface; Asthma; Atomic force microscopy; Film ultrastructure; Isotherms; Langmuir Bodgett films; Models; Surfactant inhibition

Indexed keywords

LUNG SURFACTANT; SERUM ALBUMIN;

AIRWAY; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD ANALYSIS; BRONCHIOLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; LANGMUIR BLODGETT FILM; LUNG ALVEOLUS; LUNG ALVEOLUS CELL TYPE 2; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SURFACE TENSION;

AIRWAY RESISTANCE; ANIMALS; BRONCHI; CATTLE; IMAGING, THREE-DIMENSIONAL; LUNG; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; SERUM;

EID: 34248645952     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2007.02.001     Document Type: Article

References (62)

1. Banerjee R.R. Interactions of haematological derivatives and dipalmitoyl phosphatidyl choline: implications for adult respiratory distress syndrome. Coll. Surf. B: Biointerf. 34 (2004) 95-104
2. Bernhard W., Haagsman H.P., Tscherning T., Poets C.F., Postle A.D., van Eijk M.E., and vonderHardt H. Conductive airway surfactant: surface tension function, biochemical composition and possible alveolar origin. Am. J. Respir. Cell Mol. Biol. 17 (1997) 41-50
3. Davidson K.G., Acton S.M., Barr H.A., and Nicholas T.E. Effect of lowering serum cholesterol on the composition of surfactant in adults rat lung. Am. J. Physiol. (Lung Cell Mol. Physiol.) 16 (1997) L104-L106
4. Discher B.M., Maloney K.M., Grainger D.G., Sousa C.A., and Hall S.B. Neutral lipids induce critical behaviour in interfacial monolayer of pulmonary surfactant. Biochemistry 38 (1998) 374-383
5. Enhorning G. Pulmonary surfactant function in alveoli and conducting airways. Can. Respir. J. 3 (1996) 21-27
6. Enhorning G., Hohlfeld J., Krug N., Lema G., and Wellier R.C. Surfactant function affected by airway inflammation and cooling: possible impact on exercise induced asthma. Eur. Respir. J. 15 (2000) 532-538
7. Geiser M., and Bastian S. Surface-lining layer of airways in cystic fibrosis mice. Am. J. Physiol. (Lung Cell Mol. Physiol.) 285 (2003) L1277-L1285
8. Ghadiali S.N., and Gaver III D.P. An investigation of pulmonary surfactant physicochemical behaviour under airway reopening conditions. J. Appl. Physiol. 88 (2000) 493-506
9. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim. Biophys. Acta 1408 (1998) 79-89
10. Gregory T.J., Longmore W.J., Moxley M.A., Whitsett J.A., Reed R., Fowler III A.A., Hudson L.D., Maunder R.J., Crim C., and Hyers T.M. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88 (1991) 1976-1981
11. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 13 (1999) 1455-1476
12. Grunder R., Gehr P., Bachofen H., Schürch S., and Siegenthaler H. Structures of surfactant films: a scanning force microscopy study. Eur. Respir. J. 14 (1999) 1290-1296
13. Gunashekara L., Schurch S., Schoel M.W., Nag K., Zleonenko M., Haufs M., and Amrein M. Pulmonary surfactant function is abolished by an elevated level of cholesterol. Biochim. Biophys. Acta 1737 (2005) 27-35
14. Günther A., Siebert C., Schmidt R., Ziegler S., Grimminger F., Yabut M., Temmesfeld B., Walmrath D., Morr H., and Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung oedema. Am. J. Respir. Crit. Care Med. 153 (1996) 176-184
15. Haas M.J., and Longmore W.J. Regulation of lung surfactant cholesterol metabolism by serum lipoproteins. Lipids 15 (1980) 401-408
16. Harbottle R., Nag K., McIntyre N.S., Possmayer F., and Petersen N.O. Molecular organization revealed by time of flight secondary ion mass spectrometry of a clinically used extracted pulmonary surfactant. Langmuir 19 (2003) 3698-3704
17. Hohlfeld J.M., Ahlf K., Enhorning G., Balke K., Erpenbeck V.J., Petschallies J., Hoymann A.G., Fabel H., and Krug N. Dysfunctional pulmonary surfactant in asthmatics after segmental allergen challenge. Am. J. Respir. Crit. Care Med. 159 (1999) 1803-1809
18. Hohlfeld J.M., Fabel H., and Hamm H. The role of pulmonary surfactant in obstructive airway disease. Eur. Respir. J. 10 (1997) 482-491
19. Holm B.A. Surfactant inactivation in adult respiratory distress syndrome. In: Robertson B., VanGolde L.M.G., and Batenburg J.J. (Eds). Pulmonary Surfactant: from Molecular Biology to Clinical Practice (1992), Elsevier Science Publishers, Amsterdam 665-684
20. Holm B.A., Enhorning G., and Notter R.H. A biochemical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Phys. Lipids 43 (1988) 49-55
21. Jones M.E., and Nicholas T.E. Turnover of cholesterol and dipalmitoylphosphatidylcholine in surfactant in adult rat lung. Lipids 28 (1993) 173-179
22. Kirkness J.P., Christenson H.K., Garlick S.R., Parikh R., Kairitis K., Wheatley J.R., and Amis T.C. Decreased surface tension of upper airway mucosal lining liquid increases upper airway patency in anaesthetized rabbits. J. Physiol. 547 (2003) 311-603
23. Kurashima K., Fujimura M., Matsuda T., and Kobayashi T. Surface activity of sputum from acute asthmatic patients. Am. J. Respir. Crit. Care Med. 155 (1997) 1254-1259
24. Landmann E., Gortner L., Reiss I., Weller E., and Tegtmeyer F.K. Protein content and biophysical properties of tracheal aspirates from neonates with respiratory failure. Klinische Pädiatrie 214 (2002) 1-7
25. Lang C., Postle A.D., Orgeig S., Possmayer F., Bernhard W., Panda A.K., Jurgens K.D., Milsom W.K., Nag K., and Daniels C.B. Dipalmitoylphosphatidylcholine is not the major surfactant phospholipid species in all mammals. Am. J. Physiol. 289 (2005) 1426-1439
26. Larsson M., Nylander T., Keough K.M.W., and Nag K. An X-ray diffraction study of alterations in bovine lung surfactant bilayer structures induced by albumin. Chem. Phys. Lipids 144 (2006) 137-145
27. Lathorp J., Hayes T., Carrick K., and Hammond D. Rarity gives charm: evaluation of trace proteins in plasma and serum. Expert. Rev. Proteom. 2 (2005) 293-406
28. Lewis J.F., and Veldhuizen R.A.W. Factors influencing efficacy of exogenous surfactant in acute lung injury. Biol. Neonate. 67 (1995) 48-60
29. Liu M., Wang L., and Enhoring G. Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin. Exp. Allergy 25 (1995) 1053-1060
30. Liu M.Y., Wang L.M., Li E., and Enhoring G. Pulmonary surfactant will secure free airflow through narrow tube. J. Appl. Physiol. 71 (1991) 742-748
31. Lorez C., and Lopéz J. Incidence of air pollution in the pulmonary surfactant system of the pigeon (Columba livia). Anatom. Rec. 249 (1997) 206-212
32. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin reagent. J. Biol. Chem. 193 (1951) 265-275
33. Meyer K.C., Sharma A., Brown R., Weatherly M., Moya F.R., Lewandoski J., and Zimmerman J.J. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Lab. Anim. Invest. 118 (2000) 164-174
34. Möhwald H. Phospholipid and phospholipid-protein monolayers at the air/water interface. Annu. Rev. Phys. Chem. 41 (1990) 441-476
35. Nag K., Boland C., Rich N.H., and Keough K.M.W. Design and construction of an epifluorescence microscopic surface balance for the study of lipid phase transition. Rev. Sci. Instrum. 61 (1990) 3425-3430
36. Nag K., Frederick L., Panda A.K., Rodriguez-Capote K., Hearn S.A., Schurch S., and Possmayer F. Disparate effects of two phosphatidylcholine binding proteins, C-reactive protein and surfactant protein-A, on pulmonary surfactant structure and function. Am. J. Physiol. 287 (2004) 1145-1153
37. Nag, K., Fritzen-Garcia, M., Devraj, R., Panda, A.K., 2007. Interfacial organization of gel phospholipid and cholesterol in bovine lung surfactant. Langmuir, in press.
38. Nag K., Harbottle R.R., and Panda A.K. Atomic force microscopy of interfacial films of pulmonary surfactant. In: Braga P.C., and Ricci D. (Eds). Methods in Molecular Biology: Atomic Force Microscopy, Biomedical Methods and Applications (2003), Humana Press Inc., Totowa, NJ 231-343
39. 2H-NMR. Biophys. J. 90 (2006) 3632-3642
40. Nag K., Pao J.-S., Harbottle R.R., Possmayer F., Petersen N.O., and Bagatolli L.A. Segregation of saturated chain lipids in pulmonary surfactant films and bilayers. Biophys. J. 82 (2002) 2041-2051
41. Nag K., Perez-Gil J., Ruano M.L.F., Taneva S., Rich N.H., Stewart J., Keough K.M.W., and Keough. Phase transitions in films of lung surfactant at the air-water interface. Biophys. J. 74 (1998) 2983-2995
42. Nag K., Vidyashankar S., Panda A.K., and Harbottle R.R. Chain dancing, super-cool surfactant and heavy breathing: membranes, rafts & phase transitions. In: Nag K. (Ed). Lung Surfactant Function and Disorder (2005), Taylor and Francis Group, Boca Raton, FL 145-152
43. Panda A.K., Nag K., Harbottle R.R., Rodriguez-Capote K., Veldhuizen R.A.W., Petersen N.O., and Possmayer F. Effect of acute lung injury on structure and function of pulmonary surfactant films. Am. J. Respir. Cell Mol. Biol. 30 (2004) 1-10
44. Piknova B., Schramm V., and Hall S.B. Pulmonary surfactant: phase behaviour and function. Curr. Opin. Struct. Biol. 12 (2002) 487-494
45. Possmayer F. A proposed nomenclature for pulmonary surfactant-associated proteins. Am. Rev. Respir. Dis. 138 (1988) 990-998
46. Postle T. The analysis of lung surfactant phospholipid by elecrotospray ionisation mass spectrometry-applications to disease states. Appl. Cardiopulm. Pathophysiol. 9 (2000) 286-289
47. Postle A.D., Mander A., Reid K.B.M., Wang J.Y., Wright S.M., Moustaki M., and Warner J.O. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 20 (1999) 90-98
48. Schürch S., Goerke J., and Clements J.A. Direct determination of surface tension in the lung. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 4698-4702
49. Schmidt R., Meier U., Yabut-Perez M., Walmrath D., Grimminger F., Seeger W., and Günther A. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am. J. Respir. Crit. Care Med. 163 (2001) 95-100
50. Serna J.B., Perez-Gil J., Smith A., Simonsen A.C., and Bagatolli L.A. Cholesterol Rules: direct observation of the co-existence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. J. Biol. Chem. 279 (2004) 40715-40722
51. Sims D.E., and Horne M.M. Heterogeneity of the composition and thickness of tracheal mucus in rats. Am. J. Physiol. (Lung Cell Mol. Physiol.) 273 (1997) L1036-L1041
52. Taneva S., and Keough K.M.W. Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface. Biochemistry 36 (1997) 912-922
53. Veldhuizen R., Nag K., Orgrig S., and Possmayer F. The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta 61765 (1998) 1-19
54. Voorhout W.F., Veenendaal T., Kuroki Y., Ogasawara Y., VanGolde L.M.J., and Geuze H.J.G. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells and alveolar macrophages of rat lung. J. Histochem. Cytochem. 40 (1992) 15891597
55. Warriner H.E., Ding J., Waring A.J., and Zasadzinski J.A. A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactant. Biophys. J. 82 (2002) 835-842
56. Weis R.M., and McConnell R.M. Cholesterol stabilizes the crystal-liquid interface in phospholipid monolayers. J. Phys. Chem. 89 (1985) 4453-4459
57. Worthman L.A.D., Nag K., Davis P.J., and Keough K.M.W. Cholesterol in condensed and fluid phosphatidylcholine monolayers studied by epifluorescence microscopy. Biophys. J. 72 (1997) 2569-2580
58. Wright S.M., Hockey P.M., Enhorning G., Strong P., Reid K.B.M., Holgate S.T., Djukanovic R., and Postle A.D. Altered airway surfactant phospholipids composition and lung function in asthma. J. Appl. Physiol. 89 (2000) 1283-1292
59. Yu S.H., Harding P.G.R., Smith N., and Possmayer F. Bovine pulmonary surfactant: chemical composition and physical properties. Lipids 18 (1983) 522-529
60. Yu S.H., and Possmayer F. Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcholine in surface films. J. Lipid Res. 37 (1996) 1278-1288
61. Yu S.H., and Possmayer F. Interaction of pulmonary surfactant protein A with dipalmitoylphosphatidylcholine and cholesterol at the air/water interface. J. Lipid Res. 39 (1998) 555-568
62. Zasadzinski J.A., Ding J., Warriner H.E., Bringezu F., and Waring A.J. The physics and physiology of lung surfactants. Cur. Opin. Coll. Interf. Sci. 6 (2001) 506-513